Vitamin K-dependent protein S (PROS1)

The protein contains 676 amino acids for an estimated molecular weight of 75123 Da.

 

Anticoagulant plasma protein; it is a cofactor to activated protein C in the degradation of coagulation factors Va and VIIIa. It helps to prevent coagulation and stimulating fibrinolysis. (updated: April 1, 2015)

Protein identification was indicated in the following studies:

  1. Goodman and co-workers. (2013) The proteomics and interactomics of human erythrocytes. Exp Biol Med (Maywood) 238(5), 509-518.
  2. Hegedűs and co-workers. (2015) Inconsistencies in the red blood cell membrane proteome analysis: generation of a database for research and diagnostic applications. Database (Oxford) 1-8.
  3. D'Alessandro and co-workers. (2017) Red blood cell proteomics update: is there more to discover? Blood Transfus. 15(2), 182-187.

Methods

The following articles were analysed to gather the proteome content of erythrocytes.

The gene or protein list provided in the studies were processed using the ID mapping API of Uniprot in September 2018. The number of proteins identified and mapped without ambiguity in these studies is indicated below.
Only Swiss-Prot entries (reviewed) were considered for protein evidence assignation.

PublicationIdentification 1Uniprot mapping 2Not mapped /
Obsolete
TrEMBLSwiss-Prot
Goodman (2013)2289 (gene list)227853205992269
Lange (2014)123412347281224
Hegedus (2015)2638262202352387
Wilson (2016)165815281702911068
d'Alessandro (2017)18261817201815
Bryk (2017)20902060101081942
Chu (2018)18531804553621387

1 as available in the article and/or in supplementary material
2 uniprot mapping returns all protein isoforms as one entry

The compilation of older studies can be retrieved from the Red Blood Cell Collection database.

The data and differentiation stages presented below come from the proteomic study and analysis performed by our partners of the GReX consortium, more details are available in their published work.

No sequence conservation computed yet.

This protein is annotated as membranous in Gene Ontology.


Interpro domains
Total structural coverage: 78%
Model score: 41

(right-click above to access to more options from the contextual menu)

VariantDescription
THPH5; reduced mutant protein levels and secretion
THPH5; expresses very low/undetectable PROS1 levels compared to wild-type; has impaired secretion; intracellular degradation of unsecreted material is
THPH5
THPH5
THPH5
THPH5; does not affect PROS1 production but results in 15.2-fold reduced PROS1 activity; has 5.4 fold reduced affinity for anionic phospholipid vesicl
THPH5
THPH5
THPH5
dbSNP:rs73846070
THPH5
THPH5
THPH5
THPH5
THPH5
THPH5
THPH5; the activated protein cofactor activity is inhibited by C4BPB with a dose dependency similar to that of wild-type PROS1
dbSNP:rs142805170
THPH5
THPH5
THPH5
THPH5
THPH5
THPH5
THPH5
THPH5
THPH5
dbSNP:rs144430063
THPH5
THPH5
THPH5
THPH5
Does not affect protein levels
THPH6
THPH5
THPH5
THPH5
THPH5
THPH5
THPH5
THPH5
THPH5
THPH5
THPH5
THPH5
THPH5
THPH5
THPH5
THPH5; expresses very low/undetectable PROS1 levels compared to wild-type; has impaired secretion; intracellular degradation of unsecreted material is
THPH5
THPH5
THPH5
THPH5
THPH5
THPH5
THPH5
THPH5
THPH5
dbSNP:rs767653920
THPH5
THPH5
THPH5
THPH5
THPH5
THPH5
dbSNP:rs5017712
THPH5
Variant Heerlen
THPH5
THPH5
THPH5
THPH5
THPH5
THPH5
THPH5
THPH5
a colorectal cancer sample
THPH5
dbSNP:rs184798444
THPH5
THPH5
THPH5
THPH5
dbSNP:rs139479630
THPH5
THPH5
THPH5
THPH5
THPH5
THPH5
THPH5
THPH5
THPH5
THPH5
THPH5; does not affect protein levels; the mutant is secreted at lower levels compared to wild-type
THPH5
THPH5; expresses very low/undetectable PROS1 levels compared to wild-type; has impaired secretion; intracellular degradation of unsecreted material is
THPH5
THPH5
THPH5

The reference OMIM entry for this protein is 176880

Protein s; pros1
Protein s, alpha; psa protein s pseudogene, included; prosp, included
Protein s, beta, included; psb, included
Pros2, included

DESCRIPTION

Protein S is a vitamin K-dependent plasma protein that inhibits blood clotting by serving as a nonenzymatic cofactor for activated protein C (PROC; 612283) in the inactivation of procoagulant factors V (F5; 612309) and VIII (F8; 300841). Protein S exists in 2 forms in plasma: the free, functionally active form, and the inactive form complexed with C4b-binding protein (C4BPA; 120830) (Dahlback and Stenflo, 1981).

CLONING

Lundwall et al. (1986) isolated and sequenced cDNA clones for protein S. Human protein S is a single-chain protein of 635 amino acids with 82% homology to bovine protein S. Hoskins et al. (1987) isolated cDNA for a protein S precursor. Edenbrandt et al. (1990) isolated clones corresponding to the 3-prime part of the PROS1 gene, including the thrombin (F2; 176930)-sensitive region, 4 domains that are homologous to the epidermal growth factor (EGF; 131530) precursor, the COOH-terminal part of protein S that is homologous to a plasma sex hormone binding globulin (SHBG; 182205), and the 3-prime untranslated region.

GENE FUNCTION

In human plasma, around 40% of protein S circulates as a free protein, while the remaining 60% forms a noncovalent 1:1 stoichiometric complex with the beta-chain of the complement C4b-binding protein (C4BPB; 120831) (Dahlback, 1991). This interaction is of high affinity and abolishes the anticoagulant properties of protein S. Therefore, in plasma, only the molar excess of protein S over C4BPB circulates in a free form and is active as a cofactor of activated protein C (APC) in the inactivation of the procoagulant factors Va and VIIIa (Griffin et al., 1992). Maillard et al. (1992) studied protein S synthesis and secretion by human osteosarcoma cell lines and by normal adult human osteoblast-like cells. They showed that protein S is synthesized by osteoblasts in an active form and incorporated in the mineralized matrix of bone. Previously, protein S was known to be synthesized mostly by hepatocytes. Heeb et al. (1994) presented data that demonstrated mechanisms of anticoagulant action for protein S that are independent of activated protein C and that involve direct binding to factors Xa and Va and direct inhibition of factor Xa. Anderson et al. (2003) identified protein S as the factor in serum that mediates serum-stimulated macrophage phagocytosis of apoptotic cells, a process thought to limit the development of inflammation and autoimmune disease. Flow cytometric and competitive inhibition analyses demonstrated that protein S binds exclusively to phosphatidylserine-positive apoptotic cells in a calcium-dependent manner. Anderson et al. (2003) concluded that protein S is a multifunctional protein that facilitates the clearance of early apoptotic cells in addition to regulating blood coagulation.

GENE STRUCTURE

Schmidel et al. (1990) determined that the PROS1 gene contains 15 exons and spans more than 80 kb.

MAPPING

By Southern blot analysis of DNA from somatic cell hybrids, Naylor et al. (1987) and Long et al. (1988) assigned the protein S gene to chromosome 3p21-q21. By study of somatic cell hybrids with cDNA probes, including hybrids with rearranged chromosomes, Watkins et al. (1987, 1988) assigned the protein S gene to 3p21-q21; see Stanislovitis et al. (1987). By in situ hybridization, Watkins et al. (1988) assigned the PROS gene to chromosome 3p11.1-q11.2, the region immediately surrounding the centromere. Hartz (2008) mapped the ... More on the omim web site

Subscribe to this protein entry history

Feb. 2, 2018: Protein entry updated
Automatic update: Uniprot description updated

Dec. 19, 2017: Protein entry updated
Automatic update: Uniprot description updated

June 20, 2017: Protein entry updated
Automatic update: comparative model was added.

March 16, 2016: Protein entry updated
Automatic update: OMIM entry 176880 was added.

Jan. 25, 2016: Protein entry updated
Automatic update: model status changed